Ritract Ltd Release: Australian Safety Syringe Gets Clearance To Market In The United States

June 8, 2006 |

1 min read

SYDNEY, Australia, June 8 /PRNewswire-FirstCall/ -- Ritract (ASX: RTL - News) Limited today reported US Food & Drug Administration (FDA) clearance to begin marketing its range of auto-retractable safety syringes in the USA.

FDA Approvals Regulatory Australia

MORE ON THIS TOPIC

Laptop with envelope and document with exclamation mark on screen. Receive notification, alert message, warning, get e-mail, email, spam concepts. Flat design vector illustration

FDA

UPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy

July 27, 2026

·

3 min read

·

Heather McKenzie

3D Paper Cut Pair of Lung dotted with yellow tumor bacteria infection spread across on a blue background with no text. Yellow dots as virus infection in the lungs. Vector Illustration.

Business

Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail

July 27, 2026

·

3 min read

·

Gabrielle Masson

A silhouette of a head with a pink brain inside, surrounded by various graphic elements, a light bulb, puzzle pieces, speech bubbles, a key and abstract doodles. The concept of thinking, creativity.

Approvals

Otsuka’s ADHD approval opens up new drug class with $615M opportunity

July 27, 2026

·

2 min read

·

Tristan Manalac

Chess made from China and EU, USA flags. Europe Union, USA and China relations

China

Summit, Merck must navigate new regulatory terrain in China-first cancer landscape

July 27, 2026

·

10 min read

·

Heather McKenzie